Partial breast irradiation, though an attractive alternative to whole-breast radiotherapy, is prone to movement changes of around 4 millimeters during imaging, according to research out of the Netherlands Cancer Institute in Amsterdam. That finding suggests physicians might want to take extra steps to ensure image quality and avoid unnecessary radiation.

Despite claims otherwise from President Donald Trump, the Affordable Care Act remains the law of the land—though federal actions have increased instability in the ACA’s marketplaces. Following last year’s repeal of the individual mandate, insurers are now offering short-term, non-ACA-compliant policies, which could leave a sicker, older population shopping on ACA marketplaces.

Cancer researchers are taking notice of a pair of studies published in Nature Medicine that found editing a cell’s genomes with CRISPR-Cas9 has the potential to seed cancer and may eventually generate the disease, STAT reports.

Officials from HHS are currently talking with pharmaceutical companies to pursue voluntary price cuts as part of President Donald Trump’s drug pricing plan, The Hill reports.

DALLAS, June 12, 2018 — The American Heart Association—the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke—announced today research grants totaling more than $28 million to the scientific teams that will create a new research network focused on understanding the causes of atrial fibrillation (AFib).

A Boston-area cardiologist and an advocate against nuclear weapons met with North Korean diplomats ahead of the 2018 United States-North Korea Summit in Singapore, reports WFXT, the FOX affiliate in Boston.

A Cleveland-area cardiologist who is currently serving a 20-year prison sentence for healthcare fraud, money laundering and subjecting patients to unnecessary testing is asking a judge to overturn his case, reports Cleveland.com.

A new study published in PLOS Medicine suggests people prescribed a single-pill fixed-dose drug combination (FDC) to manage hypertension are more likely to be compliant with their medication and achieve better health outcomes than those taking separate pills.

Boston Scientific said Monday it won't comment on reports rival medical device manufacturer Stryker made a takeover bid. The news was first reported by The Wall Street Journal. Stryker also stated it does not comment on potential mergers or acquisitions.

Intrinsic susceptibility biomarkers were found to successfully provide cross validation of the oxygen-enhanced MRI biomarker perfused Oxy-R when mapping tumor hypoxia in renal carcinoma, according to research published in Radiology.